You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華納藥廠(688799.SH):擬向手性藥物公司提供不超4300萬元無息借款用於實施“藥物研發項目”
格隆匯 08-05 21:14

格隆匯8月5日丨華納藥廠(688799.SH)公佈,公司於2021年8月4日召開第二屆董事會第九次會議和第二屆監事會第八次會議,審議通過《關於使用部分募集資金向全資子公司提供無息借款實施募投項目的議案》,公司新增全資子公司湖南華納大藥廠手性藥物有限公司(“手性藥物公司”)作為募投項目“藥物研發項目”的實施主體,同意向手性藥物公司提供總額不超過4300萬元的無息借款用於實施“藥物研發項目”。

在上述募投項目規定的實施週期內,在上述借款總額範圍內視項目建設實際需要分期分批向手性藥物公司提供無息借款,借款期限為實際借款之日起2年,根據項目實際情況,借款到期後可續借或提前償還。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account